From GlobeNewswire:

ThreeD Capital Inc. has closed a private placement with Sariel Diagnostics Corp., acquiring 3,750,000 common shares at $0.02 per share. In return, ThreeD issued 150,000 common shares at $0.50 per share. No commissions were paid, and all securities issued are subject to a hold period until July 23, 2024. ThreeD is a venture capital firm investing in junior resources and disruptive technologies. Investors can contact Chief Financial Officer Matthew Davis for more information at [email protected] or 416-941-8900 ext 106. Forward-looking statements in the news release should be considered with caution.



Read more at GlobeNewswire: ThreeD Capital Inc. Announces Completion of Private